News | June 15, 2022
CCI approves sale of biosimilars portfolio of Viatris to Biocon Biologics
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
Bayer now present in four of the largest biotechnology hubs in the United States
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
This agreement is in addition to the $92 million filling line expansion announced in November 2021
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)
Roche and its subsidiary TIB Molbiol have developed three different LightMix Modular Virus kits for the detection of the virus
Pemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)
Investment with representation on the Board of Directors and technical know-how
The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease
Subscribe To Our Newsletter & Stay Updated
